Studies in the field have generally used fasting glucose or clinical diagnoses of T2D as outcome measures, while in this study, which was a more sensitive test of glucose metabolism, OGTT has been used to evaluate insulin levels and glucose tolerance in relation to iron homeostasis and FA profile. The gene discussed is INS; the disease is type 2 diabetes mellitus.